VIVIMEDLAB

Vivimed Labs Share Price

 

 

Start SIP in VIVIMEDLAB

Start SIP

Performance

  • Low
  • ₹22
  • High
  • ₹22
  • 52 Week Low
  • ₹22
  • 52 Week High
  • ₹29
  • Open Price₹22
  • Previous Close₹23
  • Volume523

Investment Returns

  • Over 1 Month + 2067%
  • Over 3 Month + 2067%
  • Over 6 Month + 2067%
  • Over 1 Year + 2067%

Smart Investing Starts Here Start SIP with Vivimed Labs for Steady Growth!

Invest Now

Vivimed Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -7.4
  • PEG Ratio
  • -0.3
  • Market Cap Cr
  • 180
  • P/B Ratio
  • -2.5
  • Average True Range
  • 1.92
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.6
  • RSI
  • 73.34
  • MFI
  • 47.96

Vivimed Labs Financials

Vivimed Labs Technicals

EMA & SMA

Current Price
₹21.67
-1.14 (-5%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹13.11
  • 50 Day
  • ₹10.69
  • 100 Day
  • ₹10.39
  • 200 Day
  • ₹11.40

Resistance and Support

21.67 Pivot Speed
  • R3 21.67
  • R2 21.67
  • R1 21.67
  • S1 21.67
  • S2 21.67
  • S3 21.67

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vivimed Labs has an operating revenue of Rs. 104.12 Cr. on a trailing 12-month basis. An annual revenue de-growth of -24% needs improvement, Pre-tax margin of -27% needs improvement, NULL The stock from a technical standpoint is comfortably placed above its key moving averages, around 136% and 120% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 99 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 74 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vivimed Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results, Pref. issue & A.G.M.
2025-05-30 Audited Results
2025-02-14 Quarterly Results
2025-01-10 Quarterly Results & Others To consider other business matters.

Vivimed Labs F&O

Vivimed Labs Shareholding Pattern

7.77%
1.64%
65.17%
25.42%

About Vivimed Labs

  • NSE Symbol
  • VIVIMEDLAB
  • BSE Symbol
  • 532660
  • Managing Director
  • Mr. Santosh Varalwar
  • ISIN
  • INE526G01021

Similar Stocks to Vivimed Labs

Vivimed Labs FAQs

Vivimed Labs share price is ₹21 As on 26 December, 2025 | 01:13

The Market Cap of Vivimed Labs is ₹179.7 Cr As on 26 December, 2025 | 01:13

The P/E ratio of Vivimed Labs is -7.4 As on 26 December, 2025 | 01:13

The PB ratio of Vivimed Labs is -2.5 As on 26 December, 2025 | 01:13

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23